The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  1999-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/J.1365-2125.1999.00037.XPMID 10510163PMCID PMC2014323
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypertension causes premature aging of endothelial function in humans.

  1997cited by this paper
• Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm.

  1997cited by this paper
• Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.

  1997cited by this paper
• Basal nitric oxide synthesis in essential hypertension.

  1997cited by this paper
• Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism.

  1995cited by this paper
• Preserved endothelium-dependent vasodilatation in patients with essential hypertension.

  1994cited by this paper
• Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits.

  1994cited by this paper
• Hypertension and Left Ventricular Hypertrophy Are Associated With Impaired Endothelium‐Mediated Relaxation in Human Coronary Resistance Vessels

  1993cited by this paper
• Nebivolol in Hypertension: A Double‐Blind Placetbo‐Controlled Multicenter Study Assessing its Antihypertensive Efficacy and Impact on Quality of Life

  1993cited by this paper
• Effects of D‐Nebivolol and L‐Nebivolol on Left Ventricular Systolic and Diastolic Function: Comparison with D‐L-Nebivolol and Atenolol

  1993cited by this paper
• Exercise tolerance with nebivolol and atenolol.

  1992cited by this paper
• Nebivolol Induces Endothelium Dependent Relaxatíons of Canine Coronary Arteries

  1991cited by this paper
• Nitric oxide: an endogenous modulator of leukocyte adhesion.

  1991cited by this paper
• Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension.

  1990cited by this paper
• An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.

  1990cited by this paper
• Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension.

  1990cited by this paper
• Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.

  1989cited by this paper
• Clinical evaluation of the Accutracker II ambulatory blood pressure monitor: assessment of performance in two countries and comparison with sphygmomanometry and intra-arterial blood pressure at rest and during exercise

  1989cited by this paper
• Nebivolol is devoid of intrinsic sympathomimetic activity.

  1989cited by this paper
• Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium.

  1987cited by this paper
• Recommendations on blood pressure measurement.

  1986cited by this paper
• Recommendations on blood pressure measurement.

  1986cited by this paper
• Protection by Carbocromene and Molsidomine Against Arrhythmias Occurring During Coronary Artery Occlusion and Reperfusion in Dogs

  1985cited by this paper
• An Electrically Calibrated Plethysmograph for Direct Measurement of Limb Blood Flow

  1975cited by this paper
• The measurement of volume changes in human limbs

  1953cited by this paper

• Effect of β1/β2‐adrenoceptor blockade on β3‐adrenoceptor activity in the rat cremaster muscle artery

  2021cites this paper
• A Novel function of Nebivolol: Stimulation of Adipose-derived Stem Cell Proliferation and Inhibition of Differentiation.

  2020cites this paper
• Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients With Testicular Cancer

  2020cites this paper
• Full Issue PDF

  2019cites this paper
• A comparative study of effects of nebivolol and atenolol on blood pressure and lipid profile in patients of mild to moderate hypertension

  2018cites this paper
• In vitro evaluation of nebivolol effects on nonadrenergic noncholinergic responses in rabbit corpus cavernosum

  2018cites this paper
• Towards personalized antihypertensive therapy: innovate or denervate?

  2017cites this paper
• The Comparison of the Effects of Nebivolol and Metoprolol on Erectile Dysfunction in the Cases with Coronary Artery Bypass Surgery.

  2017cites this paper
• Nebivolol Acts as a S-Nitrosoglutathione Reductase Inhibitor

  2016cites this paper
• Endothelial dysfunction in human essential hypertension.

  2016cites this paper
• The Central Role of Endothelial Dysfunction in Cardiorenal Syndrome

  2016cites this paper
• Future Treatment of Hypertension: Shifting the Focus from Blood Pressure Lowering to Arterial Stiffness Modulation?

  2015cites this paper
• Ventricular-vascular coupling and central arterial pulse pressure

  2015cites this paper
• Effect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertension.

  2015cites this paper
• A Review of Nebivolol Pharmacology and Clinical Evidence

  2015cites this paper
• Nebivolol, But Not Metoprolol, Lowers Blood Pressure in Nitric Oxide–Sensitive Human Hypertension

  2014cites this paper
• EFFECT OF NEBIVOLOL AND METOPROLOL ON PLATELET ACTIVATION IN HYPERTENSIVE PATIENTS

  2014cites this paper
• Effects of Nebivolol Versus Metoprolol on Sodium Sensitivity and Renal Sodium Handling in Hypertensive Hispanic Postmenopausal Women

  2014cites this paper
• Cardiovascular adaptation to mudpack therapy in hypertensive subjects treated with different antihypertensive drugs.

  2014cites this paper
• Nebivolol potentiates the efficacy of PDE5 inhibitors to relax corpus cavernosum and penile arteries from diabetic patients by enhancing the NO/cGMP pathway.

  2014cites this paper
• Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan

  2014cites this paper
• Lack of difference between nebivolol/hydrochlorothiazide and metoprolol/hydrochlorothiazide on aortic wave augmentation and central blood pressure

  2013cites this paper
• Effect of Nebivolol and Lifestyle Modification on Large Artery Stiffness in Middle-Aged and Older Hypertensive Adults

  2013cites this paper
• The effect of nebivolol on P wave duration and dispersion in patients with Behçet's disease; a prospective single-arm controlled study.

  2013cites this paper
• [Nebivolol in treatment of multiple cerebral aneurysms].

  2013cites this paper
• Comparative Effects of Nebivolol and Metoprolol on Red Cell Distribution Width and Neutrophil/Lymphocyte Ratio in Patients With Newly Diagnosed Essential Hypertension

  2013cites this paper
• NEBIVOLOL ALKALMAZÁSA TÖBBSZÖRÖS AGYI ANEURYSMÁK ESETÉN

  2013cites this paper
• NEBIVOLOL A NOVEL SOMEWHAT DIFFERENT ΒETA ADRENERGIC RECEPTOR BLOCKER

  2013cites this paper
• Nebivolol: impact on cardiac and endothelial function and clinical utility

  2012cites this paper
• Nebivolol induced vasodilation of renal afferent arterioles involves 1 β 3 adrenergic receptor and nitric oxide synthase activation

  2012cites this paper
• Differential Effects of Nebivolol and Metoprolol on Insulin Sensitivity and Plasminogen Activator Inhibitor in the Metabolic Syndrome

  2012cites this paper
• Effect of nebivolol on endothelial dysfunction in patients with Behçet's disease; a prospective single-arm controlled study.

  2012cites this paper
• Effects of Antihypertensive Drugs on Endothelial Dysfunction

  2012cites this paper
• Effect of Carvedilol and Nebivolol on Oxidative Stress‐related Parameters and Endothelial Function in Patients with Essential Hypertension

  2012cites this paper
• High blood pressure and endothelial dysfunction: effects of high blood pressure medication on endothelial dysfunction and new treatments

  2012cites this paper
• Nebivolol-induced vasodilation of renal afferent arterioles involves β3-adrenergic receptor and nitric oxide synthase activation.

  2012cites this paper
• Nebivolol: An Endothelium-Friendly Selective &bgr;1-Adrenoceptor Blocker

  2012cites this paper
• Comparison of nebivolol and atenolol on blood pressure, blood sugar, and lipid profile in patients of essential hypertension

  2011cites this paper
• Efficacy and tolerability of nebivolol in stage I-II hypertension: a pooled analysis of data from three randomized, placebo-controlled monotherapy trials.

  2011cites this paper
• Effects of Nebivolol on Vascular Endothelial and Myocardial Function in Diabetes Mellitus

  2011cites this paper
• [Endothelial dysfunction: role of vasodilating betablockers in hypertension and chronic heart failure].

  2010cites this paper
• Three decades of endothelium research: from the detection of nitric oxide to the everyday implementation of endothelial function measurements in cardiovascular diseases.

  2010cites this paper
• [Advantages of vasodilating beta-blockers in congestive heart failure].

  2010cites this paper
• Nebivolol Efficacy and Safety in Patients with Stage I‐II Hypertension

  2010cites this paper
• A comparative study of nebivolol and (S) atenolol on blood pressure and heart rate on essential hypertensive patients

  2010cites this paper
• Nebivolol dilates human penile arteries and reverses erectile dysfunction in diabetic rats through enhancement of nitric oxide signaling.

  2010cites this paper
• Intérêt des bêtabloquants vasodilatateurs dans l’insuffisance cardiaque

  2010cites this paper
• Von Nobel bis Viagra: Die Geschichte eines kleinen Moleküls mit großer Wirkung: Stickstoffmonoxyd (NO)

  2010influential citation
• Tolérance aux bêtabloquants: de nouveaux horizons?

  2010cites this paper
• Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X.

  2009cites this paper
• Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension

  2009cites this paper
• Nebivolol Improves Renal Function in Patients Who Underwent Angioplasty due to Renal Artery Stenosis: A Pilot Study

  2009cites this paper
• RESEARCH PAPER Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aorta

  2009cites this paper
• Nebivolol: the somewhat-different beta-adrenergic receptor blocker.

  2009cites this paper
• Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertension

  2009cites this paper
• Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aorta

  2009cites this paper
• Nitric oxide mechanisms of nebivolol

  2009cites this paper
• Neither K + Channels Nor PI3K/Akt Mediates the Vasodilative Effect of Nebivolol on Different Types of Rat Arteries

  2009cites this paper
• Short-term treatment with a beta-blocker with vasodilative capacities improves intrarenal endothelial function in experimental renal failure.

  2009cites this paper
• Evolving Mechanisms of Action of Beta Blockers: Focus on Nebivolol

  2009cites this paper
• Continuing evolution of the role of β-blockers in the treatment of hypertension

  2008cites this paper
• Signalling transduction pathways implicated in Nebivolol-induced NO production in endothelial cells

  2008cites this paper
• Early effects of treatment with nebivolol and quinapril on endothelial function in patients with hypertension.

  2008cites this paper
• Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.

  2008cites this paper
• Nebivolol/Hydrochlorothiazide

  2008cites this paper
• Efficacy and Tolerability of Nebivolol Compared with Other Antihypertensive Drugs

  2008cites this paper
• Polymorphismes génétiques et variations interindividuelles de la réponse aux agents antihypertenseurs

  2008cites this paper
• Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.

  2008cites this paper
• Vascular Wall and Endothelium

  2008cites this paper
• Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide.

  2008cites this paper
• Nebivolol: Pharmacologic Profile of an Ultraselective, Vasodilatory β1‐Blocker

  2008cites this paper
• The Effect of Nebivolol and Atenolol on Renal and Systemic Haemodynamics in Hypertensive Patients

  2007cites this paper
• The Effect of Nebivolol on Endothelial Function in Newly Diagnosed Hypertensive Patients with and without Diastolic Dysfunction

  2007cites this paper
• Does the β-Blocker Nebivolol Increase Coronary Flow Reserve?

  2007cites this paper
• Does the beta-blocker nebivolol increase coronary flow reserve?

  2007cites this paper
• Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.

  2007cites this paper
• A review of the safety and efficacy of nebivolol in the mildly hypertensive patient.

  2007cites this paper
• Nebivolol and carvedilol induce NO-dependent coronary vasodilatation that is unlikely to be mediated by extracellular ATP in the isolated guinea pig heart

  2007cites this paper
• CHAPTERR 2 Involvemen tt of the p 3 adrenocepto r in nebivolol-induce d vasorelaxatio nn in the rat aort a

  2007cites this paper
• A review of the safety and efficacy of nebivolol in the mildly hypertensive patient

  2007cites this paper
• The Efficacy and Tolerability of Nebivolol in Hypertensive African American Patients

  2007cites this paper
• Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.

  2007cites this paper
• Nebivolol for heart failure in the elderly

  2007cites this paper
• The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension.

  2007cites this paper
• Effects of nebivolol on platelet activation in hypertensive patients: a comparative study with metoprolol.

  2007cites this paper
• The vasodilatory beta-blockers

  2007cites this paper
• Different effects of atenolol and nebivolol on coronary flow reserve

  2006cites this paper
• Radical scavenging and NO-releasing properties of selected β-adrenoreceptor antagonists

  2006cites this paper
• Relation between β-adrenoceptor stimulation and nitric oxide synthesis in vascular control

  2006cites this paper
• Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients.

  2006cites this paper
• The vascular endothelium in hypertension.

  2006cites this paper
• Nebivolol: A Novel Beta-Blocker with Nitric Oxide-Induced Vasodilatation

  2006cites this paper
• Management of Global Risk Across the Continuum of Hypertensive Heart Disease

  2006cites this paper
• [Role of the L-arginine/nitric oxide system in the action of nebivolol].

  2006cites this paper
• Nebivolol: a review of its clinical and pharmacological characteristics.

  2006cites this paper
• Targeting Nitric Oxide With Drug Therapy

  2006cites this paper
• Characterization of nitric oxide release by nebivolol and its metabolites.

  2006cites this paper
• Pharmacological mechanisms of clinically favorable properties of a selective beta1-adrenoceptor antagonist, nebivolol.

  2006cites this paper
• The latest generation of beta-blockers: New pharmacologic properties

  2006cites this paper
• EGYETEMI DOKTORI (Ph.D.) ÉRTEKEZÉS ÚJABB KLINIKAI EREDMÉNYEK BÉTA-RECEPTOR BLOKKOLÓKKAL

  2006cites this paper